Dutch Appellate Court Upholds Lipitor Patent
The decision by the Court of Appeal of The Hague in the Netherlands will delay the launch of a generic version of Lipitor by Indian generic maker Ranbaxy Laboratories Ltd. until Pfizer’s patent expires in November 2011.
Pfizer said the patent, EP 247,633, is a basic patent covering atorvastatin, the active ingredient in Lipitor.
“Today’s decision is another affirmation of...
To view the full article, register now.